Revenue: The sum of all revenue fields included for a company's operating activities.
Aktis Oncology, Inc. (AKTS) had Revenue of $3.23M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$3.23M |
$-18.32M |
|
-- |
|
$3.23M |
|
$25.93M |
|
$-22.71M |
|
$4.38M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-18.32M |
|
$-22.71M |
|
$-22.58M |
|
48.63M |
|
48.63M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$543.94M |
|
$15.29M |
|
$32.86M |
|
$576.80M |
|
$27.91M |
|
-- |
|
$42.78M |
|
$70.69M |
|
$506.11M |
|
$506.11M |
|
$506.11M |
|
53.40M |
|
| Cash Flow Statement Financials | |
$-24.24M |
|
$20.54M |
|
$337.55M |
|
$38.93M |
|
$372.78M |
|
$333.85M |
|
$3.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-703.63% |
|
-703.63% |
|
-- |
|
-567.86% |
|
-567.86% |
|
$-26.10M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-3.62% |
|
-3.62% |
|
-3.18% |
|
-3.62% |
|
$9.48 |
|
$-0.54 |
|
$-0.50 |
|